Literature DB >> 15713481

Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.

V R Juárez-González1, L Riaño-Umbarila, V Quintero-Hernández, T Olamendi-Portugal, M Ortiz-León, E Ortíz, L D Possani, B Becerril.   

Abstract

BCF2, a monoclonal antibody raised against scorpion toxin Cn2, is capable of neutralizing both, the toxin and the whole venom of the Mexican scorpion Centruroides noxius Hoffmann. The single chain antibody fragment (scFv) of BCF2 was constructed and expressed in Escherichia coli. Although its affinity for the Cn2 toxin was shown to be in the nanomolar range, it was non-neutralizing in vivo due to a low stability. In order to recover the neutralizing capacity, the scFv of BCF2 was evolved by error-prone PCR and the variants were panned by phage display. Seven improved mutants were isolated from three different libraries. One of these mutants, called G5 with one mutation at CDR1 and another at CDR2 of the light chain, showed an increased affinity to Cn2, as compared to the parental scFv. A second mutant, called B7 with a single change at framework 2 of heavy chain, also had a higher affinity. Mutants G5 and B7 were also improved in their stability but they were unable to neutralize the toxin. Finally, we constructed a variant containing the changes present in G5 and B7. The purpose of this construction was to combine the increments in affinity and stability borne by these mutants. The result was a triple mutant capable of neutralizing the Cn2 toxin. This variant showed the best affinity constant (KD=7.5x10(-11) M), as determined by surface plasmon resonance (BIAcore). The k(on) and k(off) were improved threefold and fivefold, respectively, leading to 15-fold affinity improvement. Functional stability determinations by ELISA in the presence of different concentrations of guanidinium hydrochloride (Gdn-HCl) revealed that the triple mutant is significantly more stable than the parental scFv. These results suggest that not only improving the affinity but also the stability of our scFv were important for recovering its neutralization capacity. These findings pave the way for the generation of recombinant neutralizing antisera against scorpion stings based on scFvs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713481     DOI: 10.1016/j.jmb.2004.12.060

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Attainment of 15-fold higher affinity of a Fusarium-specific single-chain antibody by directed molecular evolution coupled to phage display.

Authors:  Jin-Long Liu; Zu-Quan Hu; Shu Xing; Sheng Xue; He-Ping Li; Jing-Bo Zhang; Yu-Cai Liao
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

2.  Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

Authors:  Anne di Tommaso; Matthieu O Juste; Marie-France Martin-Eauclaire; Isabelle Dimier-Poisson; Philippe Billiald; Nicolas Aubrey
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 3.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

4.  Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor.

Authors:  Hamid Nickho; Vahid Younesi; Leili Aghebati-Maleki; Morteza Motallebnezhad; Jafar Majidi Zolbanin; Aliakbar Movassagh Pour; Mehdi Yousefi
Journal:  Bioengineered       Date:  2016-11-16       Impact factor: 3.269

5.  Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment.

Authors:  Lidia Riaño-Umbarila; Gabriel Contreras-Ferrat; Timoteo Olamendi-Portugal; Citlalli Morelos-Juárez; Gerardo Corzo; Lourival D Possani; Baltazar Becerril
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

6.  Rational library design by functional CDR resampling.

Authors:  Qi Zhao; Diane Buhr; Courtney Gunter; Jenny Frenette; Mary Ferguson; Eric Sanford; Erika Holland; Chitra Rajagopal; Melissa Batonick; Margaret M Kiss; Michael P Weiner
Journal:  N Biotechnol       Date:  2017-12-11       Impact factor: 5.079

Review 7.  Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.

Authors:  Larissa M Alvarenga; Muhammad Zahid; Anne di Tommaso; Matthieu O Juste; Nicolas Aubrey; Philippe Billiald; Julien Muzard
Journal:  Toxins (Basel)       Date:  2014-08-21       Impact factor: 4.546

8.  Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activation.

Authors:  Patrick Chinestra; Aurélien Olichon; Claire Medale-Giamarchi; Isabelle Lajoie-Mazenc; Rémi Gence; Cyril Inard; Laetitia Ligat; Jean-Charles Faye; Gilles Favre
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

9.  Generation of recombinant antibodies to rat GABAA receptor subunits by affinity selection on synthetic peptides.

Authors:  Sujatha P Koduvayur; Hélène A Gussin; Rajni Parthasarathy; Zengping Hao; Brian K Kay; David R Pepperberg
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

Review 10.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.